Mr Bruce Kahl, ATHLETIC TRAINER in Eagle, ID - Preventive Medicine

Mr Bruce Kahl, ATHLETIC TRAINER is a Preventive Medicine - Sports Medicine physician based in Eagle, Idaho. Mr Bruce Kahl is licensed to practice in Idaho (license number AT-698) and his current practice location is 574 N Park Ln, Eagle, Idaho. He can be reached at his office (for appointments etc.) via phone at (208) 350-4235.

NPI number for Mr Bruce Kahl is 1508472309 and his current mailing address is 847 N Union Way, Star, Idaho. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1508472309.

Contact Information

	Mr Bruce Kahl, ATHLETIC TRAINER
	574 N Park Ln, Eagle, ID 83616-4512
	(208) 350-4235
	Not Available

Physician's Profile

Full Name	Mr Bruce Kahl
Gender	Male
Speciality	Preventive Medicine - Sports Medicine
Location	574 N Park Ln, Eagle, Idaho
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1508472309
Provider Enumeration Date: 09/17/2020
Last Update Date: 09/17/2020

Medical Identifiers

Medical identifiers for Mr Bruce Kahl such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1508472309	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2083S0010X	Preventive Medicine - Sports Medicine	AT-698 (Idaho)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Bruce Kahl is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Bruce Kahl, ATHLETIC TRAINER 847 N Union Way, Star, ID 83669-6028 Ph: (775) 354-7900	Mr Bruce Kahl, ATHLETIC TRAINER 574 N Park Ln, Eagle, ID 83616-4512 Ph: (208) 350-4235

News Archive

TSRI chemists develop innovative method for building new drug molecules

Chemists at The Scripps Research Institute have developed a broadly useful technique for building new drug molecules and other chemical products.

New research settles measles vaccine/autism controversy

New research from the United States will hopefully settle once and for all the controversial debate about a link between the measles vaccine and autism.

China's AIDS Action Plan calls for education, condom distribution to stem spread of HIV

China's State Council, or cabinet, on Wednesday "published the country's AIDS Action Plan for the 12th Five-Year Program period (2011-2015) on the website of the Chinese government," Xinhua/China.org.cn reports.

First real-time study to test effectiveness of fertility app

In what is believed to be the first study of its kind, researchers at Georgetown University Medical Center's Institute for Reproductive Health are recruiting as many as 1,200 women to study, in real time, a smartphone app that calculates a woman's chance for pregnancy on a daily basis.

Delcath Systems achieves record quarterly product revenue in Q2 2015

Delcath Systems, Inc., a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces financial results for the three and six months ended June 30, 2015.

Mr Bruce Kahl, ATHLETIC TRAINER - Preventive Medicine in Eagle, ID